GC Genome Corporation (KOSDAQ:340450)
South Korea · Delayed Price · Currency is KRW 4,730.00
+110.00 (2.38%)
Jul 16, 2026, 3:30 PM KST
GC Genome Market Cap
GC Genome has a market cap or net worth of 111.87 billion as of July 17, 2026. Its market cap has decreased by -48.70% in one year.
Market Cap
111.87B
Enterprise Value
73.11B
Revenue
32.16B
Ranking
n/a
PE Ratio
23.72
Stock Price
4,730.00
ChartMarket Cap Chart
Since June 11, 2025, GC Genome's market cap has decreased from 262.52B to 111.87B, a decrease of -57.39%. That is a compound annual growth rate of -54.09%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 16, 2026 | 111.87B | -30.65% |
| Dec 30, 2025 | 161.30B | -38.56% |
| Jun 11, 2025 | 262.52B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 64.62T |
| Celltrion | 40.32T |
| ALTEOGEN | 14.81T |
| Samsung Epis Holdings | 9.85T |
| CMG Pharmaceutical | 124.28B |
| Dongbang Medical | 123.93B |
| SAMSUNG PHARM. Co., LTD. | 122.54B |
| AptaBio Therapeutics | 119.26B |